A Diagnostic Challenge of Methotrexate-Induced Mucositis: A Case Report
,
Abstract
Methotrexate is an anti metabolite drug that is used for treating several autoimmune diseases in low doses. It has been reported that oral ulcers occur in 11-17% of patients receiving low doses of Methotrexate. The purpose of this article is to report the Meth- otrexate-induced oral ulcers and their effects on patient’s quality of life. The patient was a 69-year-old woman with a complaint of oral ulcers. She was taking alendronate, Methotrexate, and hydroxychloroquine for osteoporosis and rheumatoid arthritis dis- eases. The possibility of bisphosphonate-induced osteonecrosis was recognized due to necrotic ulcers with mandibular bone exposure in the first therapy session. Then, a new necrotizing ulcer on the hard palate appeared in the next session. Methotrexate consumption was discontinued and folic acid was initiated. The oral ulcers were fully recovered in three weeks. Methotrexate-induced mucositis should be considered in the differential diagnosis of patients with oral ulcers who receive low-dose Metho- trexate.
[2] J. W, S. O, J. F. Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials. PLoS One 2016; 11(5): e0153740. doi: 10.1371/journal.pone.0153740
[3] Fráňová J, Fingerhutová Š, Kobrová K, Srp R, Němcová D, Hoza J, et al. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration. Pediatr Rheumatol Online J 2016; 14(1): 36-. doi: 10.1186/s12969-016-0099-z
[4] Yélamos O, Català A, Vilarrasa E, Roé E, Puig L. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion. Dermatology 2014; 229(4): 306-9. doi: 10.1159/000366501
[5] Delyon J, Ortonne N, Benayoun E, Moroch J, Wolkenstein P, Sbidian E, et al. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker. J Am Acad Dermatol 2015; 73(3): 484-90. doi: 10.1016/j.jaad.2015.06.015
[6] Yousefi Z, Sherafati G, Fani A. Uncommon toxicity of low-dose methotrexate: case report. Tehran-Univ-Med-J 2015; 73(7): 540-3.
[7] Chamorro-Petronacci C, García-García A, Lorenzo-Pouso AI, Gómez-García FJ, Padín-Iruegas ME, Gándara-Vila P, et al. Management options for low-dose methotrexate-induced oral ulcers: A systematic review. Med Oral Patol Oral Cir Bucal 2019; 24(2): e181-e9. doi: 10.4317/medoral.22851
[8] Hanakawa H, Orita Y, Sato Y, Uno K, Nishizaki K, Yoshino T. Large ulceration of the oropharynx induced by methotrexate- associated lymphoproliferative disorders. Acta Med Okayama 2013; 67(4): 265-9. doi: 10.18926/amo/51072
[9] Shea B, Swinden MV, Ghogomu ET, Ortiz Z, Katchamart W, Rader T, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. J Rheumatol 2014; 41(6): 1049-60. doi: 10.3899/jrheum.130738
[10] Sugita J, Matsushita T, Kashiwazaki H, Kosugi M, Takahashi S, Wakasa K, et al. Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD. Bone Marrow Transplant 2012; 47(2): 258-64. doi: 10.1038/bmt.2011.53
[11] Troeltzsch M, von Blohn G, Kriegelstein S, Woodlock T, Gassling V, Berndt R, et al. Oral mucositis in patients receiving low-dose methotrexate therapy for rheumatoid arthritis: report of 2 cases and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115(5): e28-33. doi: 10.1016/j.oooo.2012.12.008
[12] Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients. Autoimmun Rev 2014; 13(11): 1109-13. doi: 10.1016/j. autrev.2014.08.027
[13] Horie N, Kawano R, Kaneko T, Shimoyama T. Methotrexate- related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis. Aust Dent J 2015; 60(3): 408- 11. doi: 10.1111/adj.12235
[14] Souza CF, Suarez OM, Silva TF, Gorenstein AC, Quintella LP, Avelleira JC. Ulcerations due to methotrexate toxicity in a psoriasis patient. An Bras Dermatol 2016; 91(3): 375-7. doi: 10.1590/abd1806-4841.20163960
[15] Dervisoglou T, Matiakis A. Oral Ulceration Due to Methotrexate Treatment: A Report of 3 Cases and Literature Review. Balkan Journal of Dental Medicine 2015; 19. doi: 10.1515/bjdm-2015- 0045
| Files | ||
| Issue | Vol 7 No 2 (2022): March-April | |
| Section | Case Report(s) | |
| DOI | https://doi.org/10.18502/crcp.v7i2.10824 | |
| Keywords | ||
| Oral ulcer Mucositis Arthritis Rheumatoid Methotrexate | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
